Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV

Clinical trial NCT00319852 · COMPLETED

Trial details

NCT number: NCT00319852
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pertussis Diphtheria Poliomyelitis Tetanus

Start date: 2006-04-01
Primary completion: 2008-04-01
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.